From early beginnings as a post-WWII manufacturer of penicillin, the Eli Lilly and Company plant in Liverpool has diversified its portfolio with animal health products now responsible for the bulk of the company’s output. Tim Brown discusses current plans with the team at Lilly Speke, and finds out what’s in store for the future.
When the factory was constructed in 1945, it began manufacturing fermented healthcare products, specifically penicillin. Following the purchase of the site by Lilly in 1963, the plant began to expand its product range, and in the late 1970’s was principally focused on the manufacture of protein-based products. Today, products developed for human use have been…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
